Global Celecoxib API Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Celecoxib API market size was valued at US$ 55 million in 2023. With growing demand in downstream market, the Celecoxib API is forecast to a readjusted size of US$ 77 million by 2030 with a CAGR of 5.1% during review period.
The research report highlights the growth potential of the global Celecoxib API market. Celecoxib API are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Celecoxib API. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Celecoxib API market.
Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The Celecoxib API is the chemical compound responsible for the therapeutic effects of the drug. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it works by blocking the production of prostaglandins, which are chemicals produced by the body in response to injury or inflammation. By reducing the production of prostaglandins, Celecoxib can help relieve pain, reduce inflammation, and improve joint mobility. The Celecoxib API is typically manufactured by pharmaceutical companies in accordance with strict quality control standards to ensure its purity, potency, and safety. It is then used to produce finished dosage forms of Celecoxib, such as tablets or capsules, which are prescribed by healthcare professionals to treat various inflammatory conditions.
Global key players of celecoxib API include Pfizer, Jiangxi Synergy, ScinoPharm, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, etc. The top five players hold a share over 73%. Asia Pacific is the largest market, has a share about 43%, followed by North America and Europe, with share 28% and 25%, separately.
Key Features:
The report on Celecoxib API market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Celecoxib API market. It may include historical data, market segmentation by Type (e.g., Standard grade Celecoxib API, Micronized Celecoxib API), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Celecoxib API market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Celecoxib API market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Celecoxib API industry. This include advancements in Celecoxib API technology, Celecoxib API new entrants, Celecoxib API new investment, and other innovations that are shaping the future of Celecoxib API.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Celecoxib API market. It includes factors influencing customer ' purchasing decisions, preferences for Celecoxib API product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Celecoxib API market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Celecoxib API market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Celecoxib API market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Celecoxib API industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Celecoxib API market.
Market Segmentation:
Celecoxib API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Celecoxib API market?
What factors are driving Celecoxib API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Celecoxib API market opportunities vary by end market size?
How does Celecoxib API break out type, application?
According to our LPI (LP Information) latest study, the global Celecoxib API market size was valued at US$ 55 million in 2023. With growing demand in downstream market, the Celecoxib API is forecast to a readjusted size of US$ 77 million by 2030 with a CAGR of 5.1% during review period.
The research report highlights the growth potential of the global Celecoxib API market. Celecoxib API are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Celecoxib API. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Celecoxib API market.
Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The Celecoxib API is the chemical compound responsible for the therapeutic effects of the drug. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it works by blocking the production of prostaglandins, which are chemicals produced by the body in response to injury or inflammation. By reducing the production of prostaglandins, Celecoxib can help relieve pain, reduce inflammation, and improve joint mobility. The Celecoxib API is typically manufactured by pharmaceutical companies in accordance with strict quality control standards to ensure its purity, potency, and safety. It is then used to produce finished dosage forms of Celecoxib, such as tablets or capsules, which are prescribed by healthcare professionals to treat various inflammatory conditions.
Global key players of celecoxib API include Pfizer, Jiangxi Synergy, ScinoPharm, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, etc. The top five players hold a share over 73%. Asia Pacific is the largest market, has a share about 43%, followed by North America and Europe, with share 28% and 25%, separately.
Key Features:
The report on Celecoxib API market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Celecoxib API market. It may include historical data, market segmentation by Type (e.g., Standard grade Celecoxib API, Micronized Celecoxib API), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Celecoxib API market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Celecoxib API market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Celecoxib API industry. This include advancements in Celecoxib API technology, Celecoxib API new entrants, Celecoxib API new investment, and other innovations that are shaping the future of Celecoxib API.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Celecoxib API market. It includes factors influencing customer ' purchasing decisions, preferences for Celecoxib API product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Celecoxib API market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Celecoxib API market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Celecoxib API market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Celecoxib API industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Celecoxib API market.
Market Segmentation:
Celecoxib API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Standard grade Celecoxib API
- Micronized Celecoxib API
- Pharmaceutical
- Laboratory
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Teva Pharmaceuticals
- Viatris(Mylan)
- ScinoPharm
- Jiangxi Synergy
- Jiangsu Hengrui Medicine
- Jiangsu Chiatai Qingjiang
- Hisun Pharmaceutical Nantong
- Aurobindo Pharma
- Punjab Chemicals
What is the 10-year outlook for the global Celecoxib API market?
What factors are driving Celecoxib API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Celecoxib API market opportunities vary by end market size?
How does Celecoxib API break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Celecoxib API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Celecoxib API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Celecoxib API by Country/Region, 2019, 2023 & 2030
2.2 Celecoxib API Segment by Type
2.2.1 Standard grade Celecoxib API
2.2.2 Micronized Celecoxib API
2.3 Celecoxib API Sales by Type
2.3.1 Global Celecoxib API Sales Market Share by Type (2019-2024)
2.3.2 Global Celecoxib API Revenue and Market Share by Type (2019-2024)
2.3.3 Global Celecoxib API Sale Price by Type (2019-2024)
2.4 Celecoxib API Segment by Application
2.4.1 Pharmaceutical
2.4.2 Laboratory
2.5 Celecoxib API Sales by Application
2.5.1 Global Celecoxib API Sale Market Share by Application (2019-2024)
2.5.2 Global Celecoxib API Revenue and Market Share by Application (2019-2024)
2.5.3 Global Celecoxib API Sale Price by Application (2019-2024)
3 GLOBAL CELECOXIB API BY COMPANY
3.1 Global Celecoxib API Breakdown Data by Company
3.1.1 Global Celecoxib API Annual Sales by Company (2019-2024)
3.1.2 Global Celecoxib API Sales Market Share by Company (2019-2024)
3.2 Global Celecoxib API Annual Revenue by Company (2019-2024)
3.2.1 Global Celecoxib API Revenue by Company (2019-2024)
3.2.2 Global Celecoxib API Revenue Market Share by Company (2019-2024)
3.3 Global Celecoxib API Sale Price by Company
3.4 Key Manufacturers Celecoxib API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Celecoxib API Product Location Distribution
3.4.2 Players Celecoxib API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CELECOXIB API BY GEOGRAPHIC REGION
4.1 World Historic Celecoxib API Market Size by Geographic Region (2019-2024)
4.1.1 Global Celecoxib API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Celecoxib API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Celecoxib API Market Size by Country/Region (2019-2024)
4.2.1 Global Celecoxib API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Celecoxib API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Celecoxib API Sales Growth
4.4 APAC Celecoxib API Sales Growth
4.5 Europe Celecoxib API Sales Growth
4.6 Middle East & Africa Celecoxib API Sales Growth
5 AMERICAS
5.1 Americas Celecoxib API Sales by Country
5.1.1 Americas Celecoxib API Sales by Country (2019-2024)
5.1.2 Americas Celecoxib API Revenue by Country (2019-2024)
5.2 Americas Celecoxib API Sales by Type
5.3 Americas Celecoxib API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Celecoxib API Sales by Region
6.1.1 APAC Celecoxib API Sales by Region (2019-2024)
6.1.2 APAC Celecoxib API Revenue by Region (2019-2024)
6.2 APAC Celecoxib API Sales by Type
6.3 APAC Celecoxib API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Celecoxib API by Country
7.1.1 Europe Celecoxib API Sales by Country (2019-2024)
7.1.2 Europe Celecoxib API Revenue by Country (2019-2024)
7.2 Europe Celecoxib API Sales by Type
7.3 Europe Celecoxib API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Celecoxib API by Country
8.1.1 Middle East & Africa Celecoxib API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Celecoxib API Revenue by Country (2019-2024)
8.2 Middle East & Africa Celecoxib API Sales by Type
8.3 Middle East & Africa Celecoxib API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Celecoxib API
10.3 Manufacturing Process Analysis of Celecoxib API
10.4 Industry Chain Structure of Celecoxib API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Celecoxib API Distributors
11.3 Celecoxib API Customer
12 WORLD FORECAST REVIEW FOR CELECOXIB API BY GEOGRAPHIC REGION
12.1 Global Celecoxib API Market Size Forecast by Region
12.1.1 Global Celecoxib API Forecast by Region (2025-2030)
12.1.2 Global Celecoxib API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Celecoxib API Forecast by Type
12.7 Global Celecoxib API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Celecoxib API Product Portfolios and Specifications
13.1.3 Pfizer Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Celecoxib API Product Portfolios and Specifications
13.2.3 Teva Pharmaceuticals Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Viatris(Mylan)
13.3.1 Viatris(Mylan) Company Information
13.3.2 Viatris(Mylan) Celecoxib API Product Portfolios and Specifications
13.3.3 Viatris(Mylan) Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Viatris(Mylan) Main Business Overview
13.3.5 Viatris(Mylan) Latest Developments
13.4 ScinoPharm
13.4.1 ScinoPharm Company Information
13.4.2 ScinoPharm Celecoxib API Product Portfolios and Specifications
13.4.3 ScinoPharm Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 ScinoPharm Main Business Overview
13.4.5 ScinoPharm Latest Developments
13.5 Jiangxi Synergy
13.5.1 Jiangxi Synergy Company Information
13.5.2 Jiangxi Synergy Celecoxib API Product Portfolios and Specifications
13.5.3 Jiangxi Synergy Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Jiangxi Synergy Main Business Overview
13.5.5 Jiangxi Synergy Latest Developments
13.6 Jiangsu Hengrui Medicine
13.6.1 Jiangsu Hengrui Medicine Company Information
13.6.2 Jiangsu Hengrui Medicine Celecoxib API Product Portfolios and Specifications
13.6.3 Jiangsu Hengrui Medicine Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Jiangsu Hengrui Medicine Main Business Overview
13.6.5 Jiangsu Hengrui Medicine Latest Developments
13.7 Jiangsu Chiatai Qingjiang
13.7.1 Jiangsu Chiatai Qingjiang Company Information
13.7.2 Jiangsu Chiatai Qingjiang Celecoxib API Product Portfolios and Specifications
13.7.3 Jiangsu Chiatai Qingjiang Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Jiangsu Chiatai Qingjiang Main Business Overview
13.7.5 Jiangsu Chiatai Qingjiang Latest Developments
13.8 Hisun Pharmaceutical Nantong
13.8.1 Hisun Pharmaceutical Nantong Company Information
13.8.2 Hisun Pharmaceutical Nantong Celecoxib API Product Portfolios and Specifications
13.8.3 Hisun Pharmaceutical Nantong Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hisun Pharmaceutical Nantong Main Business Overview
13.8.5 Hisun Pharmaceutical Nantong Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma Celecoxib API Product Portfolios and Specifications
13.9.3 Aurobindo Pharma Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 Punjab Chemicals
13.10.1 Punjab Chemicals Company Information
13.10.2 Punjab Chemicals Celecoxib API Product Portfolios and Specifications
13.10.3 Punjab Chemicals Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Punjab Chemicals Main Business Overview
13.10.5 Punjab Chemicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Celecoxib API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Celecoxib API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Celecoxib API by Country/Region, 2019, 2023 & 2030
2.2 Celecoxib API Segment by Type
2.2.1 Standard grade Celecoxib API
2.2.2 Micronized Celecoxib API
2.3 Celecoxib API Sales by Type
2.3.1 Global Celecoxib API Sales Market Share by Type (2019-2024)
2.3.2 Global Celecoxib API Revenue and Market Share by Type (2019-2024)
2.3.3 Global Celecoxib API Sale Price by Type (2019-2024)
2.4 Celecoxib API Segment by Application
2.4.1 Pharmaceutical
2.4.2 Laboratory
2.5 Celecoxib API Sales by Application
2.5.1 Global Celecoxib API Sale Market Share by Application (2019-2024)
2.5.2 Global Celecoxib API Revenue and Market Share by Application (2019-2024)
2.5.3 Global Celecoxib API Sale Price by Application (2019-2024)
3 GLOBAL CELECOXIB API BY COMPANY
3.1 Global Celecoxib API Breakdown Data by Company
3.1.1 Global Celecoxib API Annual Sales by Company (2019-2024)
3.1.2 Global Celecoxib API Sales Market Share by Company (2019-2024)
3.2 Global Celecoxib API Annual Revenue by Company (2019-2024)
3.2.1 Global Celecoxib API Revenue by Company (2019-2024)
3.2.2 Global Celecoxib API Revenue Market Share by Company (2019-2024)
3.3 Global Celecoxib API Sale Price by Company
3.4 Key Manufacturers Celecoxib API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Celecoxib API Product Location Distribution
3.4.2 Players Celecoxib API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CELECOXIB API BY GEOGRAPHIC REGION
4.1 World Historic Celecoxib API Market Size by Geographic Region (2019-2024)
4.1.1 Global Celecoxib API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Celecoxib API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Celecoxib API Market Size by Country/Region (2019-2024)
4.2.1 Global Celecoxib API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Celecoxib API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Celecoxib API Sales Growth
4.4 APAC Celecoxib API Sales Growth
4.5 Europe Celecoxib API Sales Growth
4.6 Middle East & Africa Celecoxib API Sales Growth
5 AMERICAS
5.1 Americas Celecoxib API Sales by Country
5.1.1 Americas Celecoxib API Sales by Country (2019-2024)
5.1.2 Americas Celecoxib API Revenue by Country (2019-2024)
5.2 Americas Celecoxib API Sales by Type
5.3 Americas Celecoxib API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Celecoxib API Sales by Region
6.1.1 APAC Celecoxib API Sales by Region (2019-2024)
6.1.2 APAC Celecoxib API Revenue by Region (2019-2024)
6.2 APAC Celecoxib API Sales by Type
6.3 APAC Celecoxib API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Celecoxib API by Country
7.1.1 Europe Celecoxib API Sales by Country (2019-2024)
7.1.2 Europe Celecoxib API Revenue by Country (2019-2024)
7.2 Europe Celecoxib API Sales by Type
7.3 Europe Celecoxib API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Celecoxib API by Country
8.1.1 Middle East & Africa Celecoxib API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Celecoxib API Revenue by Country (2019-2024)
8.2 Middle East & Africa Celecoxib API Sales by Type
8.3 Middle East & Africa Celecoxib API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Celecoxib API
10.3 Manufacturing Process Analysis of Celecoxib API
10.4 Industry Chain Structure of Celecoxib API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Celecoxib API Distributors
11.3 Celecoxib API Customer
12 WORLD FORECAST REVIEW FOR CELECOXIB API BY GEOGRAPHIC REGION
12.1 Global Celecoxib API Market Size Forecast by Region
12.1.1 Global Celecoxib API Forecast by Region (2025-2030)
12.1.2 Global Celecoxib API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Celecoxib API Forecast by Type
12.7 Global Celecoxib API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Celecoxib API Product Portfolios and Specifications
13.1.3 Pfizer Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Celecoxib API Product Portfolios and Specifications
13.2.3 Teva Pharmaceuticals Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Viatris(Mylan)
13.3.1 Viatris(Mylan) Company Information
13.3.2 Viatris(Mylan) Celecoxib API Product Portfolios and Specifications
13.3.3 Viatris(Mylan) Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Viatris(Mylan) Main Business Overview
13.3.5 Viatris(Mylan) Latest Developments
13.4 ScinoPharm
13.4.1 ScinoPharm Company Information
13.4.2 ScinoPharm Celecoxib API Product Portfolios and Specifications
13.4.3 ScinoPharm Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 ScinoPharm Main Business Overview
13.4.5 ScinoPharm Latest Developments
13.5 Jiangxi Synergy
13.5.1 Jiangxi Synergy Company Information
13.5.2 Jiangxi Synergy Celecoxib API Product Portfolios and Specifications
13.5.3 Jiangxi Synergy Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Jiangxi Synergy Main Business Overview
13.5.5 Jiangxi Synergy Latest Developments
13.6 Jiangsu Hengrui Medicine
13.6.1 Jiangsu Hengrui Medicine Company Information
13.6.2 Jiangsu Hengrui Medicine Celecoxib API Product Portfolios and Specifications
13.6.3 Jiangsu Hengrui Medicine Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Jiangsu Hengrui Medicine Main Business Overview
13.6.5 Jiangsu Hengrui Medicine Latest Developments
13.7 Jiangsu Chiatai Qingjiang
13.7.1 Jiangsu Chiatai Qingjiang Company Information
13.7.2 Jiangsu Chiatai Qingjiang Celecoxib API Product Portfolios and Specifications
13.7.3 Jiangsu Chiatai Qingjiang Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Jiangsu Chiatai Qingjiang Main Business Overview
13.7.5 Jiangsu Chiatai Qingjiang Latest Developments
13.8 Hisun Pharmaceutical Nantong
13.8.1 Hisun Pharmaceutical Nantong Company Information
13.8.2 Hisun Pharmaceutical Nantong Celecoxib API Product Portfolios and Specifications
13.8.3 Hisun Pharmaceutical Nantong Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hisun Pharmaceutical Nantong Main Business Overview
13.8.5 Hisun Pharmaceutical Nantong Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma Celecoxib API Product Portfolios and Specifications
13.9.3 Aurobindo Pharma Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 Punjab Chemicals
13.10.1 Punjab Chemicals Company Information
13.10.2 Punjab Chemicals Celecoxib API Product Portfolios and Specifications
13.10.3 Punjab Chemicals Celecoxib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Punjab Chemicals Main Business Overview
13.10.5 Punjab Chemicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Celecoxib API Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Celecoxib API Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Standard grade Celecoxib API
Table 4. Major Players of Micronized Celecoxib API
Table 5. Global Celecoxib API Sales by Type (2019-2024) & (Kg)
Table 6. Global Celecoxib API Sales Market Share by Type (2019-2024)
Table 7. Global Celecoxib API Revenue by Type (2019-2024) & ($ million)
Table 8. Global Celecoxib API Revenue Market Share by Type (2019-2024)
Table 9. Global Celecoxib API Sale Price by Type (2019-2024) & (US$/Kg)
Table 10. Global Celecoxib API Sales by Application (2019-2024) & (Kg)
Table 11. Global Celecoxib API Sales Market Share by Application (2019-2024)
Table 12. Global Celecoxib API Revenue by Application (2019-2024)
Table 13. Global Celecoxib API Revenue Market Share by Application (2019-2024)
Table 14. Global Celecoxib API Sale Price by Application (2019-2024) & (US$/Kg)
Table 15. Global Celecoxib API Sales by Company (2019-2024) & (Kg)
Table 16. Global Celecoxib API Sales Market Share by Company (2019-2024)
Table 17. Global Celecoxib API Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Celecoxib API Revenue Market Share by Company (2019-2024)
Table 19. Global Celecoxib API Sale Price by Company (2019-2024) & (US$/Kg)
Table 20. Key Manufacturers Celecoxib API Producing Area Distribution and Sales Area
Table 21. Players Celecoxib API Products Offered
Table 22. Celecoxib API Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Celecoxib API Sales by Geographic Region (2019-2024) & (Kg)
Table 26. Global Celecoxib API Sales Market Share Geographic Region (2019-2024)
Table 27. Global Celecoxib API Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Celecoxib API Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Celecoxib API Sales by Country/Region (2019-2024) & (Kg)
Table 30. Global Celecoxib API Sales Market Share by Country/Region (2019-2024)
Table 31. Global Celecoxib API Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Celecoxib API Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Celecoxib API Sales by Country (2019-2024) & (Kg)
Table 34. Americas Celecoxib API Sales Market Share by Country (2019-2024)
Table 35. Americas Celecoxib API Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Celecoxib API Revenue Market Share by Country (2019-2024)
Table 37. Americas Celecoxib API Sales by Type (2019-2024) & (Kg)
Table 38. Americas Celecoxib API Sales by Application (2019-2024) & (Kg)
Table 39. APAC Celecoxib API Sales by Region (2019-2024) & (Kg)
Table 40. APAC Celecoxib API Sales Market Share by Region (2019-2024)
Table 41. APAC Celecoxib API Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Celecoxib API Revenue Market Share by Region (2019-2024)
Table 43. APAC Celecoxib API Sales by Type (2019-2024) & (Kg)
Table 44. APAC Celecoxib API Sales by Application (2019-2024) & (Kg)
Table 45. Europe Celecoxib API Sales by Country (2019-2024) & (Kg)
Table 46. Europe Celecoxib API Sales Market Share by Country (2019-2024)
Table 47. Europe Celecoxib API Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Celecoxib API Revenue Market Share by Country (2019-2024)
Table 49. Europe Celecoxib API Sales by Type (2019-2024) & (Kg)
Table 50. Europe Celecoxib API Sales by Application (2019-2024) & (Kg)
Table 51. Middle East & Africa Celecoxib API Sales by Country (2019-2024) & (Kg)
Table 52. Middle East & Africa Celecoxib API Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Celecoxib API Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Celecoxib API Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Celecoxib API Sales by Type (2019-2024) & (Kg)
Table 56. Middle East & Africa Celecoxib API Sales by Application (2019-2024) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Celecoxib API
Table 58. Key Market Challenges & Risks of Celecoxib API
Table 59. Key Industry Trends of Celecoxib API
Table 60. Celecoxib API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Celecoxib API Distributors List
Table 63. Celecoxib API Customer List
Table 64. Global Celecoxib API Sales Forecast by Region (2025-2030) & (Kg)
Table 65. Global Celecoxib API Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Celecoxib API Sales Forecast by Country (2025-2030) & (Kg)
Table 67. Americas Celecoxib API Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Celecoxib API Sales Forecast by Region (2025-2030) & (Kg)
Table 69. APAC Celecoxib API Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Celecoxib API Sales Forecast by Country (2025-2030) & (Kg)
Table 71. Europe Celecoxib API Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Celecoxib API Sales Forecast by Country (2025-2030) & (Kg)
Table 73. Middle East & Africa Celecoxib API Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Celecoxib API Sales Forecast by Type (2025-2030) & (Kg)
Table 75. Global Celecoxib API Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Celecoxib API Sales Forecast by Application (2025-2030) & (Kg)
Table 77. Global Celecoxib API Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Pfizer Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Celecoxib API Product Portfolios and Specifications
Table 80. Pfizer Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Teva Pharmaceuticals Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Pharmaceuticals Celecoxib API Product Portfolios and Specifications
Table 85. Teva Pharmaceuticals Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 86. Teva Pharmaceuticals Main Business
Table 87. Teva Pharmaceuticals Latest Developments
Table 88. Viatris(Mylan) Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 89. Viatris(Mylan) Celecoxib API Product Portfolios and Specifications
Table 90. Viatris(Mylan) Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 91. Viatris(Mylan) Main Business
Table 92. Viatris(Mylan) Latest Developments
Table 93. ScinoPharm Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 94. ScinoPharm Celecoxib API Product Portfolios and Specifications
Table 95. ScinoPharm Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 96. ScinoPharm Main Business
Table 97. ScinoPharm Latest Developments
Table 98. Jiangxi Synergy Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 99. Jiangxi Synergy Celecoxib API Product Portfolios and Specifications
Table 100. Jiangxi Synergy Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 101. Jiangxi Synergy Main Business
Table 102. Jiangxi Synergy Latest Developments
Table 103. Jiangsu Hengrui Medicine Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 104. Jiangsu Hengrui Medicine Celecoxib API Product Portfolios and Specifications
Table 105. Jiangsu Hengrui Medicine Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 106. Jiangsu Hengrui Medicine Main Business
Table 107. Jiangsu Hengrui Medicine Latest Developments
Table 108. Jiangsu Chiatai Qingjiang Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 109. Jiangsu Chiatai Qingjiang Celecoxib API Product Portfolios and Specifications
Table 110. Jiangsu Chiatai Qingjiang Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 111. Jiangsu Chiatai Qingjiang Main Business
Table 112. Jiangsu Chiatai Qingjiang Latest Developments
Table 113. Hisun Pharmaceutical Nantong Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 114. Hisun Pharmaceutical Nantong Celecoxib API Product Portfolios and Specifications
Table 115. Hisun Pharmaceutical Nantong Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 116. Hisun Pharmaceutical Nantong Main Business
Table 117. Hisun Pharmaceutical Nantong Latest Developments
Table 118. Aurobindo Pharma Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 119. Aurobindo Pharma Celecoxib API Product Portfolios and Specifications
Table 120. Aurobindo Pharma Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 121. Aurobindo Pharma Main Business
Table 122. Aurobindo Pharma Latest Developments
Table 123. Punjab Chemicals Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 124. Punjab Chemicals Celecoxib API Product Portfolios and Specifications
Table 125. Punjab Chemicals Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 126. Punjab Chemicals Main Business
Table 127. Punjab Chemicals Latest Developments
Table 1. Celecoxib API Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Celecoxib API Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Standard grade Celecoxib API
Table 4. Major Players of Micronized Celecoxib API
Table 5. Global Celecoxib API Sales by Type (2019-2024) & (Kg)
Table 6. Global Celecoxib API Sales Market Share by Type (2019-2024)
Table 7. Global Celecoxib API Revenue by Type (2019-2024) & ($ million)
Table 8. Global Celecoxib API Revenue Market Share by Type (2019-2024)
Table 9. Global Celecoxib API Sale Price by Type (2019-2024) & (US$/Kg)
Table 10. Global Celecoxib API Sales by Application (2019-2024) & (Kg)
Table 11. Global Celecoxib API Sales Market Share by Application (2019-2024)
Table 12. Global Celecoxib API Revenue by Application (2019-2024)
Table 13. Global Celecoxib API Revenue Market Share by Application (2019-2024)
Table 14. Global Celecoxib API Sale Price by Application (2019-2024) & (US$/Kg)
Table 15. Global Celecoxib API Sales by Company (2019-2024) & (Kg)
Table 16. Global Celecoxib API Sales Market Share by Company (2019-2024)
Table 17. Global Celecoxib API Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Celecoxib API Revenue Market Share by Company (2019-2024)
Table 19. Global Celecoxib API Sale Price by Company (2019-2024) & (US$/Kg)
Table 20. Key Manufacturers Celecoxib API Producing Area Distribution and Sales Area
Table 21. Players Celecoxib API Products Offered
Table 22. Celecoxib API Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Celecoxib API Sales by Geographic Region (2019-2024) & (Kg)
Table 26. Global Celecoxib API Sales Market Share Geographic Region (2019-2024)
Table 27. Global Celecoxib API Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Celecoxib API Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Celecoxib API Sales by Country/Region (2019-2024) & (Kg)
Table 30. Global Celecoxib API Sales Market Share by Country/Region (2019-2024)
Table 31. Global Celecoxib API Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Celecoxib API Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Celecoxib API Sales by Country (2019-2024) & (Kg)
Table 34. Americas Celecoxib API Sales Market Share by Country (2019-2024)
Table 35. Americas Celecoxib API Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Celecoxib API Revenue Market Share by Country (2019-2024)
Table 37. Americas Celecoxib API Sales by Type (2019-2024) & (Kg)
Table 38. Americas Celecoxib API Sales by Application (2019-2024) & (Kg)
Table 39. APAC Celecoxib API Sales by Region (2019-2024) & (Kg)
Table 40. APAC Celecoxib API Sales Market Share by Region (2019-2024)
Table 41. APAC Celecoxib API Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Celecoxib API Revenue Market Share by Region (2019-2024)
Table 43. APAC Celecoxib API Sales by Type (2019-2024) & (Kg)
Table 44. APAC Celecoxib API Sales by Application (2019-2024) & (Kg)
Table 45. Europe Celecoxib API Sales by Country (2019-2024) & (Kg)
Table 46. Europe Celecoxib API Sales Market Share by Country (2019-2024)
Table 47. Europe Celecoxib API Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Celecoxib API Revenue Market Share by Country (2019-2024)
Table 49. Europe Celecoxib API Sales by Type (2019-2024) & (Kg)
Table 50. Europe Celecoxib API Sales by Application (2019-2024) & (Kg)
Table 51. Middle East & Africa Celecoxib API Sales by Country (2019-2024) & (Kg)
Table 52. Middle East & Africa Celecoxib API Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Celecoxib API Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Celecoxib API Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Celecoxib API Sales by Type (2019-2024) & (Kg)
Table 56. Middle East & Africa Celecoxib API Sales by Application (2019-2024) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Celecoxib API
Table 58. Key Market Challenges & Risks of Celecoxib API
Table 59. Key Industry Trends of Celecoxib API
Table 60. Celecoxib API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Celecoxib API Distributors List
Table 63. Celecoxib API Customer List
Table 64. Global Celecoxib API Sales Forecast by Region (2025-2030) & (Kg)
Table 65. Global Celecoxib API Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Celecoxib API Sales Forecast by Country (2025-2030) & (Kg)
Table 67. Americas Celecoxib API Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Celecoxib API Sales Forecast by Region (2025-2030) & (Kg)
Table 69. APAC Celecoxib API Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Celecoxib API Sales Forecast by Country (2025-2030) & (Kg)
Table 71. Europe Celecoxib API Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Celecoxib API Sales Forecast by Country (2025-2030) & (Kg)
Table 73. Middle East & Africa Celecoxib API Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Celecoxib API Sales Forecast by Type (2025-2030) & (Kg)
Table 75. Global Celecoxib API Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Celecoxib API Sales Forecast by Application (2025-2030) & (Kg)
Table 77. Global Celecoxib API Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Pfizer Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Celecoxib API Product Portfolios and Specifications
Table 80. Pfizer Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Teva Pharmaceuticals Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Pharmaceuticals Celecoxib API Product Portfolios and Specifications
Table 85. Teva Pharmaceuticals Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 86. Teva Pharmaceuticals Main Business
Table 87. Teva Pharmaceuticals Latest Developments
Table 88. Viatris(Mylan) Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 89. Viatris(Mylan) Celecoxib API Product Portfolios and Specifications
Table 90. Viatris(Mylan) Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 91. Viatris(Mylan) Main Business
Table 92. Viatris(Mylan) Latest Developments
Table 93. ScinoPharm Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 94. ScinoPharm Celecoxib API Product Portfolios and Specifications
Table 95. ScinoPharm Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 96. ScinoPharm Main Business
Table 97. ScinoPharm Latest Developments
Table 98. Jiangxi Synergy Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 99. Jiangxi Synergy Celecoxib API Product Portfolios and Specifications
Table 100. Jiangxi Synergy Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 101. Jiangxi Synergy Main Business
Table 102. Jiangxi Synergy Latest Developments
Table 103. Jiangsu Hengrui Medicine Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 104. Jiangsu Hengrui Medicine Celecoxib API Product Portfolios and Specifications
Table 105. Jiangsu Hengrui Medicine Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 106. Jiangsu Hengrui Medicine Main Business
Table 107. Jiangsu Hengrui Medicine Latest Developments
Table 108. Jiangsu Chiatai Qingjiang Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 109. Jiangsu Chiatai Qingjiang Celecoxib API Product Portfolios and Specifications
Table 110. Jiangsu Chiatai Qingjiang Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 111. Jiangsu Chiatai Qingjiang Main Business
Table 112. Jiangsu Chiatai Qingjiang Latest Developments
Table 113. Hisun Pharmaceutical Nantong Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 114. Hisun Pharmaceutical Nantong Celecoxib API Product Portfolios and Specifications
Table 115. Hisun Pharmaceutical Nantong Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 116. Hisun Pharmaceutical Nantong Main Business
Table 117. Hisun Pharmaceutical Nantong Latest Developments
Table 118. Aurobindo Pharma Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 119. Aurobindo Pharma Celecoxib API Product Portfolios and Specifications
Table 120. Aurobindo Pharma Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 121. Aurobindo Pharma Main Business
Table 122. Aurobindo Pharma Latest Developments
Table 123. Punjab Chemicals Basic Information, Celecoxib API Manufacturing Base, Sales Area and Its Competitors
Table 124. Punjab Chemicals Celecoxib API Product Portfolios and Specifications
Table 125. Punjab Chemicals Celecoxib API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 126. Punjab Chemicals Main Business
Table 127. Punjab Chemicals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Celecoxib API
Figure 2. Celecoxib API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Celecoxib API Sales Growth Rate 2019-2030 (Kg)
Figure 7. Global Celecoxib API Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Celecoxib API Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Standard grade Celecoxib API
Figure 10. Product Picture of Micronized Celecoxib API
Figure 11. Global Celecoxib API Sales Market Share by Type in 2023
Figure 12. Global Celecoxib API Revenue Market Share by Type (2019-2024)
Figure 13. Celecoxib API Consumed in Pharmaceutical
Figure 14. Global Celecoxib API Market: Pharmaceutical (2019-2024) & (Kg)
Figure 15. Celecoxib API Consumed in Laboratory
Figure 16. Global Celecoxib API Market: Laboratory (2019-2024) & (Kg)
Figure 17. Global Celecoxib API Sales Market Share by Application (2023)
Figure 18. Global Celecoxib API Revenue Market Share by Application in 2023
Figure 19. Celecoxib API Sales Market by Company in 2023 (Kg)
Figure 20. Global Celecoxib API Sales Market Share by Company in 2023
Figure 21. Celecoxib API Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Celecoxib API Revenue Market Share by Company in 2023
Figure 23. Global Celecoxib API Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Celecoxib API Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Celecoxib API Sales 2019-2024 (Kg)
Figure 26. Americas Celecoxib API Revenue 2019-2024 ($ Millions)
Figure 27. APAC Celecoxib API Sales 2019-2024 (Kg)
Figure 28. APAC Celecoxib API Revenue 2019-2024 ($ Millions)
Figure 29. Europe Celecoxib API Sales 2019-2024 (Kg)
Figure 30. Europe Celecoxib API Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Celecoxib API Sales 2019-2024 (Kg)
Figure 32. Middle East & Africa Celecoxib API Revenue 2019-2024 ($ Millions)
Figure 33. Americas Celecoxib API Sales Market Share by Country in 2023
Figure 34. Americas Celecoxib API Revenue Market Share by Country in 2023
Figure 35. Americas Celecoxib API Sales Market Share by Type (2019-2024)
Figure 36. Americas Celecoxib API Sales Market Share by Application (2019-2024)
Figure 37. United States Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Celecoxib API Sales Market Share by Region in 2023
Figure 42. APAC Celecoxib API Revenue Market Share by Regions in 2023
Figure 43. APAC Celecoxib API Sales Market Share by Type (2019-2024)
Figure 44. APAC Celecoxib API Sales Market Share by Application (2019-2024)
Figure 45. China Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Celecoxib API Sales Market Share by Country in 2023
Figure 53. Europe Celecoxib API Revenue Market Share by Country in 2023
Figure 54. Europe Celecoxib API Sales Market Share by Type (2019-2024)
Figure 55. Europe Celecoxib API Sales Market Share by Application (2019-2024)
Figure 56. Germany Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Celecoxib API Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Celecoxib API Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Celecoxib API Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Celecoxib API Sales Market Share by Application (2019-2024)
Figure 65. Egypt Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Celecoxib API in 2023
Figure 71. Manufacturing Process Analysis of Celecoxib API
Figure 72. Industry Chain Structure of Celecoxib API
Figure 73. Channels of Distribution
Figure 74. Global Celecoxib API Sales Market Forecast by Region (2025-2030)
Figure 75. Global Celecoxib API Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Celecoxib API Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Celecoxib API Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Celecoxib API Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Celecoxib API Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Celecoxib API
Figure 2. Celecoxib API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Celecoxib API Sales Growth Rate 2019-2030 (Kg)
Figure 7. Global Celecoxib API Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Celecoxib API Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Standard grade Celecoxib API
Figure 10. Product Picture of Micronized Celecoxib API
Figure 11. Global Celecoxib API Sales Market Share by Type in 2023
Figure 12. Global Celecoxib API Revenue Market Share by Type (2019-2024)
Figure 13. Celecoxib API Consumed in Pharmaceutical
Figure 14. Global Celecoxib API Market: Pharmaceutical (2019-2024) & (Kg)
Figure 15. Celecoxib API Consumed in Laboratory
Figure 16. Global Celecoxib API Market: Laboratory (2019-2024) & (Kg)
Figure 17. Global Celecoxib API Sales Market Share by Application (2023)
Figure 18. Global Celecoxib API Revenue Market Share by Application in 2023
Figure 19. Celecoxib API Sales Market by Company in 2023 (Kg)
Figure 20. Global Celecoxib API Sales Market Share by Company in 2023
Figure 21. Celecoxib API Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Celecoxib API Revenue Market Share by Company in 2023
Figure 23. Global Celecoxib API Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Celecoxib API Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Celecoxib API Sales 2019-2024 (Kg)
Figure 26. Americas Celecoxib API Revenue 2019-2024 ($ Millions)
Figure 27. APAC Celecoxib API Sales 2019-2024 (Kg)
Figure 28. APAC Celecoxib API Revenue 2019-2024 ($ Millions)
Figure 29. Europe Celecoxib API Sales 2019-2024 (Kg)
Figure 30. Europe Celecoxib API Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Celecoxib API Sales 2019-2024 (Kg)
Figure 32. Middle East & Africa Celecoxib API Revenue 2019-2024 ($ Millions)
Figure 33. Americas Celecoxib API Sales Market Share by Country in 2023
Figure 34. Americas Celecoxib API Revenue Market Share by Country in 2023
Figure 35. Americas Celecoxib API Sales Market Share by Type (2019-2024)
Figure 36. Americas Celecoxib API Sales Market Share by Application (2019-2024)
Figure 37. United States Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Celecoxib API Sales Market Share by Region in 2023
Figure 42. APAC Celecoxib API Revenue Market Share by Regions in 2023
Figure 43. APAC Celecoxib API Sales Market Share by Type (2019-2024)
Figure 44. APAC Celecoxib API Sales Market Share by Application (2019-2024)
Figure 45. China Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Celecoxib API Sales Market Share by Country in 2023
Figure 53. Europe Celecoxib API Revenue Market Share by Country in 2023
Figure 54. Europe Celecoxib API Sales Market Share by Type (2019-2024)
Figure 55. Europe Celecoxib API Sales Market Share by Application (2019-2024)
Figure 56. Germany Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Celecoxib API Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Celecoxib API Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Celecoxib API Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Celecoxib API Sales Market Share by Application (2019-2024)
Figure 65. Egypt Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Celecoxib API Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Celecoxib API in 2023
Figure 71. Manufacturing Process Analysis of Celecoxib API
Figure 72. Industry Chain Structure of Celecoxib API
Figure 73. Channels of Distribution
Figure 74. Global Celecoxib API Sales Market Forecast by Region (2025-2030)
Figure 75. Global Celecoxib API Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Celecoxib API Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Celecoxib API Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Celecoxib API Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Celecoxib API Revenue Market Share Forecast by Application (2025-2030)
